organic compounds
6-Methyl-4-oxo-4H-chromene-3-carbaldehyde
aH.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan
*Correspondence e-mail: dr.sammer.yousuf@gmail.com
In the title compound, C11H8O3, the benzopyran-4-one or chromone ring system is almost planar, with a maximum deviation of 0.045 (2) Å. The is stablized by π–π interactions between the benzene and pyran rings of inversion-related molecules stacked along the b axis, with a centroid–centroid distance of 3.5463 (12) Å
Related literature
For the biological activity of chromone, see: Patel et al. (2011); Khan et al. (2009, 2010); Gautam et al. (2010); Ishar et al. (2006); Hassan (1992); Nohara et al. (1974). For a related structure, see: Wang & Kong (2007).
Experimental
Crystal data
|
Data collection: SMART (Bruker, 2000); cell SAINT (Bruker, 2000); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL, PARST (Nardelli, 1995) and PLATON (Spek, 2009).
Supporting information
https://doi.org/10.1107/S1600536812037555/rz2798sup1.cif
contains datablocks global, I. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S1600536812037555/rz2798Isup2.hkl
Supporting information file. DOI: https://doi.org/10.1107/S1600536812037555/rz2798Isup3.cml
The title compound was synthesized by taking dry dimethylformamide (12.32 ml) into a three necked flask followed by slow addition of POCl3 (49 mmol) with intensive stirring at 50°C. Heating and stirring was continued for 2 h at 45–55°C. A solution of 5-methyl-2-hydroxyacetophenone (10 mmol) in DMF was then slowly added under stirring at 50°C. The stirring was continued for additional 2 h at 55–60°C. After cooling, the mixture was kept over night at room temperature and diluted slowly by adding crushed ice (300 g) and stirred again for 6 h to obtain the crude product. Recrystallization from ethanol afforded crystals in 78.7% yield (1.48 g) which were found suitable for single-crystal X-ray diffraction studies. All chemicals were purchased by sigma Aldrich Germany.
H atoms were positioned geometrically with C—H = 0.93–0.95 Å and constrained to ride on their parent atoms with Uiso(H)= 1.5Ueq(CH3) or 1.2Ueq(CH).
Chromone is a heterocyclic compound containing a benzene ring fused with a pyran ring, so it is also called as benzopyran-4-one. Chromone moieties are associated with various physiological and biological properties such as antibacterial (Patel et al., 2011), antioxidant (Gautam et al., 2010; Hassan et al., 1992), antianaphylactic (Nohara et al., 1974), antiinflammatory (Khan et al., 2010), anticancer (Ishar et al., 2006), and thymidine phosphorylase inhibitor (Khan et al., 2009) activities. The title compound is a chromone derivative synthesized as a part of our ongoing research to study different biological activities of this medicinally important class of organic compounds and establish their structure–activity relationship.
The structure of title compound (Fig. 1) is composed of a planar chromone moiety (O1/C1–C9) with maximum deviation of 0.045 (2) Å for atom C8. Bond lengths and angles are similar to those observed in a structurally related compound (Wang & Kong, 2007). In the crystal (Fig. 2), inversion-related molecules are linked along the b axis by significant π–π stacking interactions occurring between benzene and pyran rings of chromone moeities, with centroid-centroid distances of 3.5463 (12) Å.
For the biological activity of chromone, see: Patel et al. (2011); Khan et al. (2010); (2009); Gautam et al. (2010); Ishar et al. (2006); Hassan (1992); Nohara et al. (1974). For a related structure, see: Wang & Kong (2007).
Data collection: SMART (Bruker, 2000); cell
SAINT (Bruker, 2000); data reduction: SAINT (Bruker, 2000); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008), PARST (Nardelli, 1995) and PLATON (Spek, 2009).Fig. 1. The molecular structure of the title compound with displacement ellipsoids drawn at the 30% probability level. | |
Fig. 2. The crystal packing of the title compound viewed along the a axis. |
C11H8O3 | Z = 2 |
Mr = 188.17 | F(000) = 196 |
Triclinic, P1 | Dx = 1.431 Mg m−3 |
Hall symbol: -P 1 | Mo Kα radiation, λ = 0.71073 Å |
a = 6.6945 (7) Å | Cell parameters from 1636 reflections |
b = 7.1079 (7) Å | θ = 3.2–28.1° |
c = 10.3032 (11) Å | µ = 0.11 mm−1 |
α = 71.593 (2)° | T = 273 K |
β = 84.962 (2)° | Block, colorles |
γ = 69.843 (2)° | 0.26 × 0.23 × 0.11 mm |
V = 436.57 (8) Å3 |
Bruker SMART APEX CCD area-detector diffractometer | 1629 independent reflections |
Radiation source: fine-focus sealed tube | 1300 reflections with I > 2σ(I) |
Graphite monochromator | Rint = 0.019 |
ω scan | θmax = 25.5°, θmin = 2.1° |
Absorption correction: multi-scan (SADABS; Bruker, 2000) | h = −8→8 |
Tmin = 0.973, Tmax = 0.989 | k = −8→8 |
4974 measured reflections | l = −12→12 |
Refinement on F2 | Secondary atom site location: difference Fourier map |
Least-squares matrix: full | Hydrogen site location: inferred from neighbouring sites |
R[F2 > 2σ(F2)] = 0.049 | H-atom parameters constrained |
wR(F2) = 0.152 | w = 1/[σ2(Fo2) + (0.0852P)2 + 0.0886P] where P = (Fo2 + 2Fc2)/3 |
S = 1.07 | (Δ/σ)max < 0.001 |
1629 reflections | Δρmax = 0.26 e Å−3 |
128 parameters | Δρmin = −0.19 e Å−3 |
0 restraints | Extinction correction: SHELXTL (Sheldrick, 2008), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4 |
Primary atom site location: structure-invariant direct methods | Extinction coefficient: 0.013 (9) |
C11H8O3 | γ = 69.843 (2)° |
Mr = 188.17 | V = 436.57 (8) Å3 |
Triclinic, P1 | Z = 2 |
a = 6.6945 (7) Å | Mo Kα radiation |
b = 7.1079 (7) Å | µ = 0.11 mm−1 |
c = 10.3032 (11) Å | T = 273 K |
α = 71.593 (2)° | 0.26 × 0.23 × 0.11 mm |
β = 84.962 (2)° |
Bruker SMART APEX CCD area-detector diffractometer | 1629 independent reflections |
Absorption correction: multi-scan (SADABS; Bruker, 2000) | 1300 reflections with I > 2σ(I) |
Tmin = 0.973, Tmax = 0.989 | Rint = 0.019 |
4974 measured reflections |
R[F2 > 2σ(F2)] = 0.049 | 0 restraints |
wR(F2) = 0.152 | H-atom parameters constrained |
S = 1.07 | Δρmax = 0.26 e Å−3 |
1629 reflections | Δρmin = −0.19 e Å−3 |
128 parameters |
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
x | y | z | Uiso*/Ueq | ||
O1 | 0.2834 (2) | 0.1857 (2) | 0.62203 (13) | 0.0573 (4) | |
O2 | −0.30931 (18) | 0.3149 (2) | 0.47149 (12) | 0.0476 (4) | |
O3 | −0.2182 (3) | 0.2434 (3) | 0.87960 (15) | 0.0749 (5) | |
C1 | 0.2333 (3) | 0.2150 (3) | 0.34035 (18) | 0.0415 (4) | |
H1A | 0.3724 | 0.1795 | 0.3703 | 0.050* | |
C2 | 0.1952 (3) | 0.2394 (3) | 0.20506 (19) | 0.0455 (5) | |
C3 | −0.0162 (3) | 0.2971 (3) | 0.16259 (19) | 0.0497 (5) | |
H3A | −0.0452 | 0.3169 | 0.0717 | 0.060* | |
C4 | −0.1816 (3) | 0.3252 (3) | 0.25048 (19) | 0.0494 (5) | |
H4A | −0.3210 | 0.3642 | 0.2199 | 0.059* | |
C5 | −0.1371 (3) | 0.2942 (3) | 0.38609 (18) | 0.0397 (4) | |
C6 | −0.2734 (3) | 0.2855 (3) | 0.60304 (19) | 0.0443 (5) | |
H6A | −0.3894 | 0.2953 | 0.6604 | 0.053* | |
C7 | −0.0835 (3) | 0.2431 (3) | 0.65872 (18) | 0.0396 (4) | |
C8 | 0.1067 (3) | 0.2197 (3) | 0.57661 (18) | 0.0386 (4) | |
C9 | 0.0686 (3) | 0.2422 (2) | 0.43295 (17) | 0.0360 (4) | |
C10 | 0.3734 (4) | 0.2037 (4) | 0.1063 (2) | 0.0654 (6) | |
H10A | 0.5069 | 0.1645 | 0.1524 | 0.098* | |
H10B | 0.3537 | 0.3308 | 0.0316 | 0.098* | |
H10C | 0.3733 | 0.0931 | 0.0717 | 0.098* | |
C11 | −0.0697 (3) | 0.2176 (3) | 0.8057 (2) | 0.0548 (5) | |
H11A | 0.0649 | 0.1784 | 0.8440 | 0.066* |
U11 | U22 | U33 | U12 | U13 | U23 | |
O1 | 0.0400 (8) | 0.0876 (10) | 0.0504 (8) | −0.0238 (7) | −0.0042 (6) | −0.0252 (7) |
O2 | 0.0330 (7) | 0.0611 (8) | 0.0441 (7) | −0.0130 (6) | −0.0026 (5) | −0.0121 (6) |
O3 | 0.0733 (11) | 0.1117 (13) | 0.0537 (9) | −0.0380 (10) | 0.0201 (8) | −0.0413 (9) |
C1 | 0.0385 (9) | 0.0444 (10) | 0.0434 (10) | −0.0157 (8) | 0.0003 (7) | −0.0138 (8) |
C2 | 0.0522 (11) | 0.0442 (10) | 0.0401 (10) | −0.0176 (8) | 0.0025 (8) | −0.0117 (8) |
C3 | 0.0609 (12) | 0.0530 (11) | 0.0348 (9) | −0.0209 (9) | −0.0073 (8) | −0.0087 (8) |
C4 | 0.0436 (10) | 0.0553 (11) | 0.0459 (11) | −0.0163 (9) | −0.0118 (8) | −0.0077 (8) |
C5 | 0.0373 (9) | 0.0369 (9) | 0.0423 (10) | −0.0120 (7) | −0.0017 (7) | −0.0085 (7) |
C6 | 0.0389 (10) | 0.0465 (10) | 0.0440 (10) | −0.0114 (8) | 0.0043 (7) | −0.0133 (8) |
C7 | 0.0419 (10) | 0.0387 (9) | 0.0403 (10) | −0.0145 (7) | 0.0017 (8) | −0.0141 (7) |
C8 | 0.0369 (9) | 0.0385 (9) | 0.0427 (9) | −0.0131 (7) | −0.0033 (7) | −0.0137 (7) |
C9 | 0.0372 (9) | 0.0325 (8) | 0.0384 (9) | −0.0124 (7) | −0.0024 (7) | −0.0094 (7) |
C10 | 0.0634 (14) | 0.0885 (16) | 0.0457 (11) | −0.0245 (12) | 0.0091 (10) | −0.0256 (11) |
C11 | 0.0550 (12) | 0.0696 (13) | 0.0482 (11) | −0.0241 (10) | 0.0037 (9) | −0.0262 (10) |
O1—C8 | 1.227 (2) | C4—H4A | 0.9300 |
O2—C6 | 1.335 (2) | C5—C9 | 1.385 (2) |
O2—C5 | 1.383 (2) | C6—C7 | 1.339 (3) |
O3—C11 | 1.196 (2) | C6—H6A | 0.9300 |
C1—C2 | 1.385 (3) | C7—C8 | 1.455 (2) |
C1—C9 | 1.396 (2) | C7—C11 | 1.475 (3) |
C1—H1A | 0.9300 | C8—C9 | 1.473 (2) |
C2—C3 | 1.399 (3) | C10—H10A | 0.9600 |
C2—C10 | 1.505 (3) | C10—H10B | 0.9600 |
C3—C4 | 1.368 (3) | C10—H10C | 0.9600 |
C3—H3A | 0.9300 | C11—H11A | 0.9300 |
C4—C5 | 1.387 (3) | ||
C6—O2—C5 | 117.99 (13) | C6—C7—C8 | 120.85 (16) |
C2—C1—C9 | 121.75 (17) | C6—C7—C11 | 118.72 (16) |
C2—C1—H1A | 119.1 | C8—C7—C11 | 120.43 (16) |
C9—C1—H1A | 119.1 | O1—C8—C7 | 123.32 (16) |
C1—C2—C3 | 117.68 (17) | O1—C8—C9 | 122.63 (16) |
C1—C2—C10 | 121.76 (18) | C7—C8—C9 | 114.04 (15) |
C3—C2—C10 | 120.56 (17) | C5—C9—C1 | 118.08 (16) |
C4—C3—C2 | 122.15 (17) | C5—C9—C8 | 119.66 (16) |
C4—C3—H3A | 118.9 | C1—C9—C8 | 122.26 (16) |
C2—C3—H3A | 118.9 | C2—C10—H10A | 109.5 |
C3—C4—C5 | 118.60 (17) | C2—C10—H10B | 109.5 |
C3—C4—H4A | 120.7 | H10A—C10—H10B | 109.5 |
C5—C4—H4A | 120.7 | C2—C10—H10C | 109.5 |
O2—C5—C9 | 122.29 (16) | H10A—C10—H10C | 109.5 |
O2—C5—C4 | 116.01 (15) | H10B—C10—H10C | 109.5 |
C9—C5—C4 | 121.69 (16) | O3—C11—C7 | 125.06 (19) |
O2—C6—C7 | 125.04 (16) | O3—C11—H11A | 117.5 |
O2—C6—H6A | 117.5 | C7—C11—H11A | 117.5 |
C7—C6—H6A | 117.5 | ||
C9—C1—C2—C3 | 1.3 (3) | C6—C7—C8—C9 | −1.3 (2) |
C9—C1—C2—C10 | −178.14 (16) | C11—C7—C8—C9 | 177.95 (15) |
C1—C2—C3—C4 | −1.3 (3) | O2—C5—C9—C1 | 176.96 (14) |
C10—C2—C3—C4 | 178.17 (18) | C4—C5—C9—C1 | −1.9 (3) |
C2—C3—C4—C5 | −0.3 (3) | O2—C5—C9—C8 | −3.7 (3) |
C6—O2—C5—C9 | 0.8 (2) | C4—C5—C9—C8 | 177.44 (15) |
C6—O2—C5—C4 | 179.73 (15) | C2—C1—C9—C5 | 0.3 (3) |
C3—C4—C5—O2 | −176.99 (15) | C2—C1—C9—C8 | −179.10 (15) |
C3—C4—C5—C9 | 2.0 (3) | O1—C8—C9—C5 | −175.79 (16) |
C5—O2—C6—C7 | 2.0 (3) | C7—C8—C9—C5 | 3.7 (2) |
O2—C6—C7—C8 | −1.6 (3) | O1—C8—C9—C1 | 3.6 (3) |
O2—C6—C7—C11 | 179.14 (16) | C7—C8—C9—C1 | −176.89 (14) |
C6—C7—C8—O1 | 178.25 (17) | C6—C7—C11—O3 | −4.4 (3) |
C11—C7—C8—O1 | −2.5 (3) | C8—C7—C11—O3 | 176.35 (19) |
Experimental details
Crystal data | |
Chemical formula | C11H8O3 |
Mr | 188.17 |
Crystal system, space group | Triclinic, P1 |
Temperature (K) | 273 |
a, b, c (Å) | 6.6945 (7), 7.1079 (7), 10.3032 (11) |
α, β, γ (°) | 71.593 (2), 84.962 (2), 69.843 (2) |
V (Å3) | 436.57 (8) |
Z | 2 |
Radiation type | Mo Kα |
µ (mm−1) | 0.11 |
Crystal size (mm) | 0.26 × 0.23 × 0.11 |
Data collection | |
Diffractometer | Bruker SMART APEX CCD area-detector |
Absorption correction | Multi-scan (SADABS; Bruker, 2000) |
Tmin, Tmax | 0.973, 0.989 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 4974, 1629, 1300 |
Rint | 0.019 |
(sin θ/λ)max (Å−1) | 0.606 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.049, 0.152, 1.07 |
No. of reflections | 1629 |
No. of parameters | 128 |
H-atom treatment | H-atom parameters constrained |
Δρmax, Δρmin (e Å−3) | 0.26, −0.19 |
Computer programs: SMART (Bruker, 2000), SAINT (Bruker, 2000), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), SHELXTL (Sheldrick, 2008), PARST (Nardelli, 1995) and PLATON (Spek, 2009).
Acknowledgements
The authors are thankful to OPCW, The Netherlands, and the Higher Education Commission (HEC) Pakistan (project No. 1910) for their financial support.
References
Bruker (2000). SADABS, SMART and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA. Google Scholar
Gautam, R., Srivastava, A., Jachak, S. M. & Saklani, A. (2010). Fitoterapia, 81, 45–49. Web of Science CrossRef PubMed Google Scholar
Hassan, A. M. A. (1992). J. Chem. Soc. Pak. 14, 108–110. Google Scholar
Ishar, M. P. S., Singh, G., Singh, S., Sreenivasan, K. K. & Singh, G. (2006). Bioorg. Med. Chem. Lett. 16, 1366–1370. Web of Science CrossRef PubMed CAS Google Scholar
Khan, K. M., Ambreen, N., Hussain, S., Perveen, S. & Choudhary, M. I. (2009). Bioorg. Med. Chem. 17, 2983–2987. Web of Science CrossRef PubMed CAS Google Scholar
Khan, K. M., Ambreen, N., Mughal, U. R., Jalil, S., Perveen, S. & Choudhary, M. I. (2010). Eur. J. Med. Chem. 45, 4058–4064. Web of Science CrossRef CAS PubMed Google Scholar
Nardelli, M. (1995). J. Appl. Cryst. 28, 659. CrossRef IUCr Journals Google Scholar
Nohara, A., Umetani, T., Ukawa, K. & Sanno, Y. (1974). Chem. Pharm. Bull. 22, 2959–2965. CrossRef CAS PubMed Google Scholar
Patel, M. C., Nilesh, N. G. & Rajani, D. P. (2011). Der Pharma Chem. 3, 422–432. CAS Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Spek, A. L. (2009). Acta Cryst. D65, 148–155. Web of Science CrossRef CAS IUCr Journals Google Scholar
Wang, X.-B. & Kong, L.-Y. (2007). Acta Cryst. E63, o4340. Web of Science CSD CrossRef IUCr Journals Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
Chromone is a heterocyclic compound containing a benzene ring fused with a pyran ring, so it is also called as benzopyran-4-one. Chromone moieties are associated with various physiological and biological properties such as antibacterial (Patel et al., 2011), antioxidant (Gautam et al., 2010; Hassan et al., 1992), antianaphylactic (Nohara et al., 1974), antiinflammatory (Khan et al., 2010), anticancer (Ishar et al., 2006), and thymidine phosphorylase inhibitor (Khan et al., 2009) activities. The title compound is a chromone derivative synthesized as a part of our ongoing research to study different biological activities of this medicinally important class of organic compounds and establish their structure–activity relationship.
The structure of title compound (Fig. 1) is composed of a planar chromone moiety (O1/C1–C9) with maximum deviation of 0.045 (2) Å for atom C8. Bond lengths and angles are similar to those observed in a structurally related compound (Wang & Kong, 2007). In the crystal (Fig. 2), inversion-related molecules are linked along the b axis by significant π–π stacking interactions occurring between benzene and pyran rings of chromone moeities, with centroid-centroid distances of 3.5463 (12) Å.